The diagnosis of AML with TP53 mutation takes precedence over AML with myelodysplasia-related cytogenetic anomalies (AML-MRC) due to the poor prognosis TP53 mutations convey [10, 11]. The gene discussed is TP53; the disease is acute myeloid leukemia.